Steinunn Sara Helgudóttir, PhD

Steinunn Sara Helgudóttir, PhD

Steinunn completed her doctorate at the Neurobiology Research and Drug Delivery Group at Aalborg University. She conducted research on targeted drug delivery through the blood-brain barrier.
Viktória Reháková

Viktória Reháková

Viktória successfully completed her master’s degree in Neuroscience from the University of Copenhagen. Her research primarily revolved around exploring neuronal excitability, examining structural changes in excitable domains of motoneurons, and investigating...
AI speeds up the R&D for ALS treatment

AI speeds up the R&D for ALS treatment

Today we speak to Dr. Vang Le-Quy at Aalborg University, about how his team is collaborating with Dr. John Nieland, 2N Pharma Co-Founder and his research group at Aalborg University’s Health Science and Technology Department, in the search for a cure to Amyotrophic...
The 2N Pharma Team – Michael Sloth Trabjerg

The 2N Pharma Team – Michael Sloth Trabjerg

Last month, Michael Sloth Trabjerg, Scientific Adviser for 2N Pharma successfully completed the defence of his PhD research into lipid metabolism dysfunction in Amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) at Aalborg University. In...